MENU
Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 08, 2023

TLRY Bullish Market Trend: RSI Oscillator Predicts 80% Upward Shift

Market Neutral Strategy (TA&FA) with TLRY: A Statistical Perspective on the Bullish Trend

The Trading Analysis (TA) and Fundamental Analysis (FA) insights into Tilray, Inc. (TLRY) reveal an increasingly positive outlook. The technical indicators, including the RSI Oscillator, Stochastic Oscillator, and MACD, along with the recent price performance, all point towards a strong likelihood of continued price appreciation.

The Relative Strength Index (RSI) - a momentum oscillator that measures the speed and change of price movements - for TLRY indicates a shifting trend from downward to upward. Out of 45 instances where TLRY's RSI Indicator exited the oversold territory, 36 resulted in a price increase. This translates to an 80% probability of the stock price continuing its upward trend, as suggested by Tickeron's analysis.

Meanwhile, the Stochastic Oscillator - another momentum indicator comparing a particular closing price of a security to a range of its prices over a certain period of time - reinforces the RSI's upward trend prediction for TLRY. After exiting the oversold zone, the Stochastic Oscillator has historically led to an increase in TLRY's price in 53 out of 66 cases, implying an 80% probability of a continued upward trend.

The Moving Average Convergence Divergence (MACD) for TLRY, which is used to identify possible buy and sell signals, turned positive on June 21, 2023. This is a bullish signal that suggests upward price momentum. Historical data shows that when TLRY's MACD turned positive, the stock continued its rise in 36 out of 47 instances over the subsequent month. This suggests a 77% likelihood of TLRY maintaining its upward trajectory.

In addition, the recent +5.26% 3-day advance for TLRY offers a further hint at the stock's potential for more gains. History shows that in 179 of 220 situations where TLRY advanced for three consecutive days, the price climbed even further within the following month. This statistical occurrence suggests an 81% chance of a continued upward trend.

These insights project an optimistic future for TLRY. The combination of RSI, Stochastic Oscillator, and MACD analyses along with the recent price movements put TLRY in a promising light for those considering a market-neutral strategy. This TA&FA approach for TLRY has yielded a commendable 12.29% return, showcasing the potential of this strategy in choppy market conditions and reinforcing the advantage of employing multiple technical indicators to predict market trends.

Related Ticker: TLRY

TLRY in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 13, 2025

TLRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where TLRY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for TLRY's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

TLRY moved below its 50-day moving average on October 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TLRY crossed bearishly below the 50-day moving average on November 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLRY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TLRY entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.612) is normal, around the industry mean (16.613). P/E Ratio (0.000) is within average values for comparable stocks, (73.373). TLRY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.953). TLRY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.917) is also within normal values, averaging (55.744).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TLRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.24B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 4%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 17%. PROCF experienced the highest price growth at 390%, while BSPK experienced the biggest fall at -35%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -18%. For the same stocks of the Industry, the average monthly volume growth was -29% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 62
Price Growth Rating: 58
SMR Rating: 79
Profit Risk Rating: 89
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
TLRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TLRY showed earnings on October 09, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a holding company, whose subsidiaries engages in research, cultivation, processing and distribution of medical cannabis

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
265 Talbot Street West
Phone
+1 844 845-7291
Employees
1600
Web
https://www.tilray.com
Interact to see
Advertisement
NVIDIA’s earnings on May 28 could jolt the tech sector. With market volatility rising, traders are turning to Tickeron’s AI Agent for real-time insights, predictive analytics, and dual-strategy trading tools to navigate potential price swings and seize market opportunities.
#artificial_intelligence
As the DOJ and FTC move to break up Google’s search dominance and impose AI investment oversight, the tech giant faces a pivotal legal battle that could reshape the digital and AI landscapes—creating major implications for investors, competitors, and consumers alike.
#artificial_intelligence
GameStop (GME) continues to captivate investors with its explosive volatility and strong retail sentiment. As AI tools highlight bullish signals and a possible breakout, traders weigh the risks of speculation against the potential rewards in May 2025.
#artificial_intelligence
Mastercard (MA) continues to impress investors with strong earnings, rising digital payments, and bullish AI-driven signals. Backed by robust financials and cutting-edge trading tools from Tickeron, MA stands out as a leader in the fintech space for 2025.
From Walmart's retail resilience to Exxon Mobil's energy strength, May 2025 highlights key market movers. Discover how Tickeron’s AI bots analyze WMT, IVW, COST, and XOM—uncovering trends, boosting trading strategies, and navigating market volatility with precision.
#trading#artificial_intelligence
A powerful recession signal is flashing red: the Leading/Lagging Ratio has plunged to levels not seen since 2008. As markets grow turbulent, smart investors are turning to Tickeron’s AI trading agents to spot opportunities and stay ahead of the downturn.
#trading#artificial_intelligence
AI trading bots are no longer just experimental—they’re outperforming traditional strategies. Discover how bots trading ITA, TSM, META, and others achieved over 40% annual returns and what this means for the future of investing.
FingerMotion (FNGR) is making waves in 2025 with a 52% stock surge, strategic AI expansion into Indonesia, and strong retail momentum. Learn how traders are using correlation analysis, inverse ETFs, and Tickeron’s AI tools to navigate FNGR’s dynamic moves.
#artificial_intelligence#trading
Ferrari (RACE) is accelerating in 2025 with a 25% YTD gain, strong earnings, and bullish momentum fueled by innovation and Lewis Hamilton’s F1 move. Discover how Tickeron’s AI tools help traders capitalize on this luxury stock’s high-performance potential.
Intel’s stock is down 64%, but a bold turnaround under new CEO Lip-Bu Tan and the upcoming 18A chip rollout could spark a rebound. This article explores Intel’s financials, strategic shifts, and how AI tools from Tickeron help traders navigate the volatility.
#artificial_intelligence
Dogecoin (DOGE) fell 12.78% in five days, rattled by whale activity, Musk headlines, and ETF rumors. Is a breakout coming—or more downside? Explore key trends, technical levels, and how Tickeron’s AI bots help traders navigate DOGE’s next move.
The week of June 2-6, 2025, saw financial markets demonstrate resilience amid U.S.-China trade tensions and key economic data releases.
Tesla, Inc. (TSLA), a global leader in electric vehicles (EVs) and artificial intelligence (AI)-driven technologies, has been a focal point for investors in 2025.
#artificial_intelligence#trading
As artificial intelligence continues to reshape the financial industry, AI-powered trading agents have emerged as influential tools in portfolio management and speculative trading.
#investment#artificial_intelligence
Amazon (NASDAQ: AMZN) remains a cornerstone of the technology and e-commerce sectors, consistently driving innovation and market influence.
#artificial_intelligence
ntroduction to Eli Lilly and Company (LLY) Eli Lilly and Company (LLY), a global pharmaceutical giant, has been a cornerstone of the healthcare sector since its founding in 1876. Headquartered in Indianapolis, Indiana, the company specializes in developing innovative treatments for diabetes, oncology, immunology, and neuroscience, with blockbuster drugs like Mounjaro and Zepbound driving significant…
Tickeron, a leader in AI-driven financial solutions, announces the launch of its latest AI trading robot designed for five high-profile stocks: Amazon.com, Inc. (AMZN), Taiwan Semiconductor Manufacturing Company, Ltd. (TSM), Walmart Inc. (WMT), Google LLC (GOOG), and Meta Platforms Inc. (META).
MicroAlgo Inc. ($MLGO), a company focused on developing advanced algorithms and AI-driven solutions, has garnered attention in the financial markets due to its volatile price movements and potential for significant upside.
Tickeron, a leader in AI-driven financial solutions, proudly announces the exceptional performance of its XAR AI Trading Agent, achieving a remarkable +62% return and an 84.16% profitable trade rate for the SPDR S&P Aerospace & Defense ETF (XAR).
#artificial_intelligence#trading
The week of June 9-13, 2025, was characterized by significant market volatility driven by both positive developments in US-China trade relations and escalating geopolitical tensions in the Middle East.